Glutathionylated Protein Detection via Thiol Blocking and Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective systems and techniques for determining the spatial locations and concentrations of glutathionylated or otherwise oxidized proteins within cells and tissues, which is crucial for diagnosing oxidative stress conditions.
Innovation Solution
The method involves providing a sample from a subject, exposing it to an alkylating agent to react with thiol moieties on proteins, and then using a reducing agent to convert glutathionylated moieties into thiol moieties, which can then be reacted with a detection entity to determine the presence and extent of glutathionylation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional detection methods are used, then general protein detection is possible, but specific detection of glutathionylated proteins with spatial information is not achievable
Solution Approach 1:
The detection method is segmented into distinct sequential steps: (1) blocking native thiol groups with alkylating agent, (2) reducing glutathionylated moieties to free thiols, and (3) labeling newly exposed thiols with detection entity. This segmentation allows specific detection of glutathionylated proteins while maintaining spatial information through immunofluorescence microscopy.
Solution Approach 2:
The method performs preliminary blocking of native thiol groups with an alkylating agent before detection. This preliminary action prevents false positive signals from non-glutathionylated proteins and ensures that only proteins that have undergone glutathionylation will show detection signals after the reduction and labeling steps.
2Quantity of substance
If glutathionylated proteins are detected without blocking native thiols, then all thiol-containing proteins are detected, but specific glutathionylation events cannot be identified
Solution Approach 1:
The method extracts and isolates the specific signal from glutathionylated proteins by first removing (blocking) the background signal from native thiol groups. The alkylating agent selectively modifies native thiols, and subsequent reduction of glutathionylated moieties exposes only the newly formed thiols for labeling, effectively extracting the specific glutathionylation signal from the total thiol protein background.
3Productivity
If direct labeling of glutathionylated proteins is attempted, then rapid detection is possible, but the mixed disulfide bonds cannot be specifically targeted
Solution Approach 1:
The method uses a reducing agent as an intermediary to convert glutathionylated moieties into free thiol groups. This intermediary step allows the detection entity (which targets free thiols) to specifically recognize and label only those proteins that were previously glutathionylated, while native thiols remain blocked. This mediator enables both speed and specificity by creating a unique molecular signature for glutathionylated proteins.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the accurate diagnosis of oxidative stress conditions by allowing for the visualization and quantification of glutathionylated proteins within cells and tissues, providing valuable insights into redox signaling and cellular health.
Implementation Method 1
exposing the sample to an alkylating agent able to react a first thiol moiety on a protein to produce an alkylthio moiety
Implementation Method 2
exposing the sample to a reducing agent able to react a glutathionylated moiety on the protein to produce a second thiol moiety
Data Source
AI summary
The present invention, in some aspects, relates to systems and methods for determining oxidized proteins, including glutathionylated proteins such as S-glutathionylated proteins. The systems and methods of the invention can be used in vitro (e.g., in cell or tissue culture) or in vivo, for example, to diagnose a person having an oxidative stress condition. For instance, in some cases, the invention can be used to spatially determine the location and/or concentration of oxidized proteins within cells and/or tissues (e.g., through visual detection).